再添“智造”引擎，海淀北部这一生物智造产业园开园

Core Viewpoint - The opening of the Zhongguancun (Haidian) Biomanufacturing Industrial Park (B Zone) aims to address critical pain points in the pharmaceutical and health industry, facilitating the entire process from research and development to mass production [1] Group 1: Industry Development - The park focuses on high-end research and intelligent manufacturing in the biopharmaceutical sector, targeting innovative drug development, advanced medical devices, and cell and gene therapy (CGT) [1] - It aims to build a comprehensive industrial ecosystem covering R&D offices, pilot testing, CDMO/CMO services, and intelligent production, leveraging Haidian District's research resources and talent [1] Group 2: Infrastructure and Facilities - The park covers an area of approximately 33,400 square meters, with a total construction area of 59,600 square meters, consisting of five production plants and one service support building [3] - The design of the plants emphasizes "flexible adaptation," allowing for customizable space layouts to meet the diverse needs of biopharmaceutical companies [3] - The park's facilities are tailored to meet the specific requirements of biopharmaceutical enterprises, including attributes suitable for GMP clean rooms and specialized laboratories [3] Group 3: Service and Support Systems - The park features a "smart park management platform" for seamless data and business integration, enabling services like policy application, equipment sharing, and talent recruitment [4] - A "one enterprise, one file" digital management model allows for dynamic tracking of enterprise needs, providing precise and rapid response services [4] - Specialized technical platforms, including public service, inspection and testing, instrument sharing, and experimental animal platforms, are established to enhance efficiency and reduce costs in R&D [4] Group 4: Ecosystem Integration - The park is a key component of a 960,000 square meter pharmaceutical health industry ecosystem in northern Haidian, linking with the already operational Biomanufacturing Industrial Park (A Zone), Haixing Pharmaceutical Health Innovation Park (C Zone), and the under-construction Zhongguancun Science City International Medical Valley [5]